Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 19 results:
Author [ Title(Desc)] Type Year
Filters: Author is Hughes, C. M.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
B. M. Hicks, Murray, L. J., Powe, D. G., Hughes, C. M., and Cardwell, C. R., “beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort”, Ann Oncol, vol. 24, pp. 3100-6, 2013.
D
R. A. Karasneh, Murray, L. J., Menamin, U. C. Mc, Hughes, C. M., and Cardwell, C. R., “Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study”, Breast Cancer Res Treat, vol. 151, pp. 661-9, 2015.
R. A. Karasneh, Murray, L. J., Hughes, C. M., and Cardwell, C. R., “Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study”, Cancer Epidemiol Biomarkers Prev, vol. 24, pp. 1804-7, 2015.
R. A. Karasneh, Murray, L. J., Hughes, C. M., and Cardwell, C. R., “Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1099-103, 2016.
E
M. A. O'Rorke, Murray, L. J., Hughes, C. M., Cantwell, M. M., and Cardwell, C. R., “The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink”, Cancer Causes Control, vol. 26, pp. 355-66, 2015.
C. R. Cardwell, Abnet, C. C., Veal, P., Hughes, C. M., Cantwell, M. M., and Murray, L. J., “Exposure to oral bisphosphonates and risk of cancer”, Int J Cancer, vol. 131, pp. E717-25, 2012.
L
U. C. Mc Menamin, Cardwell, C. R., Hughes, C. M., and Murray, L. M., “Low-dose aspirin and survival from lung cancer: a population-based cohort study”, BMC Cancer, vol. 15, p. 911, 2015.
C. R. Cardwell, Flahavan, E. M., Hughes, C. M., Coleman, H. G., O'Sullivan, J. M., Powe, D. G., and Murray, L. J., “Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink”, Cancer Causes Control, vol. 25, pp. 33-43, 2014.
M
U. C. Mc Menamin, Murray, L. J., Hughes, C. M., and Cardwell, C. R., “Metformin use and survival after colorectal cancer: A population-based cohort study”, Int J Cancer, vol. 138, pp. 369-79, 2016.
U. C. Menamin, Cardwell, C. R., Hughes, C. M., and Murray, L. M., “Metformin use and survival from lung cancer: A population-based cohort study”, Lung Cancer, vol. 94, pp. 35-9, 2016.
N
F. J. Bannon, O'Rorke, M. A., Murray, L. J., Hughes, C. M., Gavin, A. T., Fleming, S. J., and Cardwell, C. R., “Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink”, Cancer Causes Control, vol. 24, pp. 2027-34, 2013.
J. C. Wilson, O'Rorke, M. A., Cooper, J. A., Murray, L. J., Hughes, C. M., Gormley, G. J., and Anderson, L. A., “Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink”, Cancer Epidemiol, vol. 37, pp. 897-904, 2013.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., Napolitano, G., and Murray, L. J., “Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study”, Br J Cancer, vol. 102, pp. 1415-21, 2010.
P
L. J. Murray, Cooper, J. A., Hughes, C. M., Powe, D. G., and Cardwell, C. R., “Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink”, Breast Cancer Res, vol. 16, p. R34, 2014.
M. C. Bradley, Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., and Hughes, C. M., “Potentially inappropriate prescribing among older people in the United Kingdom”, BMC Geriatr, vol. 14, p. 72, 2014.
M. C. Bradley, Murray, L. J., Cantwell, M. M., and Hughes, C. M., “Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study”, Br J Cancer, vol. 106, pp. 233-9, 2012.
S
C. R. Cardwell, U. Menamin, M., Hughes, C. M., and Murray, L. J., “Statin use and survival from lung cancer: a population-based cohort study”, Cancer Epidemiol Biomarkers Prev, vol. 24, pp. 833-41, 2015.
A. D. Spence, Busby, J., Hughes, C. M., Johnston, B. T., Coleman, H. G., and Cardwell, C. R., “Statin use and survival in patients with gastric cancer in two independent population-based cohorts”, Pharmacoepidemiol Drug Saf, 2018.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., and Murray, L. J., “Statins and pancreatic cancer risk: a nested case-control study”, Cancer Causes Control, vol. 21, pp. 2093-100, 2010.
[Page last reviewed 4 May 2021]